ACS Nano Impact Factor

• whether the journal has the citation visibility you want
• whether ACS Nano sits in the prestige range you are targeting
• whether the journal belongs on the shortlist with other strong nanoscience venues

• whether your manuscript fits the scope
• whether the editor will desk reject on novelty
• how fast the first decision will come back
• whether your article type is actually welcomed

The 2024 JIF of 16.0 is up from 15.8 in 2023, marking a small recovery from the post-pandemic normalization. The important thing here is not one isolated number. It is the pattern. ACS Nano has stayed in the same high-visibility band across recent JCR cycles, which means the citation profile is stable enough to be useful in journal planning.

That stability matters more than authors usually realize. A journal that spikes once can look more prestigious than it really is. ACS Nano looks more durable than that. The five-year JIF being close to the annual JIF reinforces the same point.

ACS Nano is often the journal authors choose when the paper is too substantial for a broad mid-tier materials venue but not obviously a Nature or Science story. It rewards strong nanoscience positioning, real mechanism, and broader relevance to the field.

Nano Letters can be a better home when the contribution is narrower but more novelty-heavy. Advanced Functional Materials becomes more attractive when the manuscript is really about functional performance, applications, or device-facing materials science. Small is often the more flexible fallback when the nano story is strong but the editorial bar at ACS Nano may be too tight.

ACS Nano does not behave like a pure metric target. Editors screen hard for:

• a clear nano-specific contribution, not a generic materials paper with nanoscale language added late
• enough mechanistic evidence to justify the main claim
• competitive benchmarking if the paper is about performance
• a story that matters beyond one narrow synthesis variation

If the paper is mainly incremental optimization, the impact factor does not help you. The scope and editorial threshold matter more.

In our pre-submission review work across nanoscience manuscripts, three rejection patterns appear consistently at ACS Nano:

The "nano label on a materials paper" problem. The title says nanoparticles, but the contribution is a synthesis protocol with no size-dependent property demonstration. ACS Nano editors have seen this framing thousands of times. The nano angle needs to be the result of something scientifically interesting, not just a description of scale.

Beautiful images, no mechanism. Stunning HRTEM or cryo-EM characterization followed by a single schematic labeled "proposed mechanism." ACS Nano reviewers don't count schematics as mechanistic evidence. If the main claim rests on a proposed pathway, you need direct evidence for that pathway, isotope labeling, in situ measurements, computational support, or equivalent.

Device performance without benchmarking. A supercapacitor paper reporting 450 F/g that doesn't cite the 10 most recent competing papers. Reviewers will build that comparison table themselves, and if your numbers sit in the middle of the literature rather than at the top, the paper reads as incremental. A performance claim without honest benchmarking is a fast rejection trigger.

These patterns don't show up in the author guidelines. They come from editorial practice, and knowing them before submission is the difference between a desk rejection in 48 hours and a paper that gets to review.

Use the impact factor as a shortlist filter, then ask the harder submission questions:

• Is the manuscript clearly nano-specific, not just nanoscale by description?
• Are the claims supported by mechanism, not only performance?
• Is the benchmarking good enough for a competitive nanoscience venue?
• Would a more application-facing journal actually be the more realistic target?

That is the real decision sequence. The JIF helps you place ACS Nano in the market. It does not replace the fit call.

The most common mistake is reading a high impact factor as proof that the journal is simply "better" than its alternatives. For submission planning, that is too crude.

Authors also overestimate how much the number compensates for weak editorial fit. A paper can look strong on citations, novelty language, or device performance and still fail fast if the editor sees it as too incremental, too descriptive, or too far outside the journal's center of gravity.

The better use of the metric is comparative:

• if you want a high-visibility nano journal, ACS Nano belongs in the discussion
• if you are choosing between several realistic journals, the impact factor helps you rank visibility
• if the scope fit is shaky, the metric should not persuade you to submit anyway

That is why strong authors use ACS Nano's JIF as context, not as the argument.

This page helps with market position, not final targeting. If you are choosing between ACS Nano and a near-peer journal for a real submission this month, you still need the companion questions: scope fit, editor behavior, review expectations, and desk-rejection risk. The metric page is useful, but the actual submission decision should always move beyond the metric page.

That is where the journal-fit decision actually happens.

Submit if:

• The paper has a clear nano-specific contribution with solid mechanistic evidence, not just nanoscale language added to generic materials work
• Benchmarking against competing approaches is competitive and fair, as editors screen hard for this
• The story matters beyond one narrow synthesis variation and has broad relevance to the nanoscience or nanotechnology community
• You have a clear nanoscience narrative supported by mechanism, not only by device performance metrics

Think twice if:

• The manuscript is mainly incremental optimization without a clear advance in understanding or capability
• The work is really application-facing or device-performance-focused, where Advanced Functional Materials may be a better fit
• The contribution is narrower but very novelty-heavy, in which case Nano Letters may be the stronger target
• The nano framing is cosmetic and the paper is fundamentally a generic materials science or synthesis paper

The JCI of 2.34 is the honest benchmark. ACS Nano papers are cited roughly 2.3 times the global average when normalized across fields. That's strong but notably lower than Nature Nanotechnology (JCI ~5.5), which publishes fewer, higher-impact papers.

ACS Nano's review culture reflects ACS editorial standards:

1. Complete characterization. Reviewers expect every material to be characterized by at least 3 independent techniques. TEM, XRD, XPS, DLS, or equivalent. Missing characterization triggers immediate revision.
2. Reproducibility data. Batch-to-batch variation for nanoparticle synthesis, replicate measurements for device performance. Single-run data isn't sufficient.
3. Application relevance. Pure synthesis without a demonstrated application is getting harder to publish here. Reviewers want to see why the material matters, not just that it was made.
4. Toxicity or biocompatibility data for biomedical applications. If you're proposing drug delivery or imaging applications, reviewers expect at minimum in vitro cytotoxicity data.
5. Scalability discussion. Reviewers increasingly ask whether the synthesis can be scaled beyond lab bench. A paragraph on practical scalability is now expected, even if full-scale data isn't available.

An ACS Nano characterization check can verify whether the characterization suite meets the journal's completeness standard before you submit.

Not all ACS Nano papers are created equal when it comes to citations. The journal spans a wide range of nanoscience topics, and certain subfields consistently outperform others in citation impact. Understanding these patterns helps you gauge whether your paper's topic aligns with where ACS Nano's readers are most engaged.

Energy nanomaterials dominate ACS Nano's most-cited papers because the community is large, the funding is substantial, and the application stakes are high. Biomedical nano benefits from the same dynamic, clinical relevance drives citation volume. For authors in more specialized subfields like nano-fabrication or environmental nano, the honest question is whether ACS Nano's broad readership will find your work or whether a more focused journal would deliver better per-paper visibility. The journal's 2,421 articles per year mean every paper competes for attention. An ACS Nano subfield positioning check identifies whether the cross-field appeal is strong enough for ACS Nano's editorial screen or whether a specialized venue would deliver better per-paper visibility.

ACS Nano's IF has been remarkably stable over the past eight years, hovering between 13.7 and 18.0. That stability tells a story about the journal's position in nanoscience, it's neither rising rapidly like a breakout journal nor declining like a fading brand. It's settled into its tier.

The 5-year JIF of 16.4 sitting close to the annual JIF of 16.0 confirms there's no hidden trend, ACS Nano papers get cited at a consistent rate over time. Compare this to Nature Nanotechnology (IF ~36), which occupies a clearly higher tier with far fewer papers, or Nano Letters (~15), which publishes shorter, sharper studies at a similar IF. ACS Nano's competitive position is secure: it's the go-to venue for substantial nanoscience papers that need breadth, depth, and application relevance. The journal isn't going to jump to 25 or drop to 10 anytime soon. For submission planning, that predictability is an asset, you know what you're getting.

1. ACS Nano journal information and aims

• ACS Nano - Journal Homepage
• ACS Nano - Author Guidelines